Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection

NCT05767528 · clinicaltrials.gov ↗

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Muscle-Invasive Bladder Carcinoma

Interventions

DIAGNOSTIC_TEST: Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]